DRUG · Mapped RxNorm record
Celecoxib
Normalized identity: celecoxibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
NCT00136487
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedCelecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
CelecoxibDRUG · verified · RxNorm: celecoxib
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
Pfizercollaborator
Beth Israel Deaconess Medical Centercollaborator
Emerson Hospital, Concord, MAcollaborator
Brigham and Women's Hospitalcollaborator
Hartford Hospitalcollaborator
Lowell General Hospitalcollaborator
Massachusetts General Hospitalcollaborator
M.D. Anderson Cancer Centercollaborator
University of Michigan Rogel Cancer Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00136487 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.